Cardiovascular Pharmacotherapy

Showing 24 of 1293 results

Pharmacological prevention: too young or too old?
Congress Session
Pharmacological prevention: too young or too old?
31 August 2026
Artificial intelligence in cardiometabolic drug discovery: from molecular insight to regulatory approval
Congress Session
Artificial intelligence in cardiometabolic drug discovery: from molecular insight to regulatory approval
31 August 2026
Cardiometabolic pharmacotherapy and cardiovascular outcomes
Congress Session
Cardiometabolic pharmacotherapy and cardiovascular outcomes
31 August 2026
Polypharmacy in cardiovascular disease: prioritisation, safety, and implementation
Congress Session
Polypharmacy in cardiovascular disease: prioritisation, safety, and implementation
31 August 2026
Therapeutic advancements in type 2 diabetes mellitus
Congress Session
Therapeutic advancements in type 2 diabetes mellitus
31 August 2026
Contemporary beta‑blocker pharmacotherapy
Congress Session
Contemporary beta‑blocker pharmacotherapy
31 August 2026
Implementing novel lipid‑lowering therapies
Congress Session
Implementing novel lipid‑lowering therapies
31 August 2026
Cardiotoxicity of drugs: machine learning and aortic stenosis
Congress Session
Cardiotoxicity of drugs: machine learning and aortic stenosis
31 August 2026
Immunisation and the heart in the post-pandemic era
Congress Session
Immunisation and the heart in the post-pandemic era
30 August 2026
Updates on dual antiplatelet therapy
Congress Session
Updates on dual antiplatelet therapy
30 August 2026
Optimal cardiovascular pharmacotherapy for the frail patient?
Congress Session
Optimal cardiovascular pharmacotherapy for the frail patient?
30 August 2026
Updates on single and combined antithrombotic therapy
Congress Session
Updates on single and combined antithrombotic therapy
30 August 2026
Pharmacotherapy of aldosterone signalling and drug‑related myocardial injury
Congress Session
Pharmacotherapy of aldosterone signalling and drug‑related myocardial injury
30 August 2026
Cardiovascular epidemic: tackling low-density lipoprotein driven cardiovascular risk
Congress Session
Cardiovascular epidemic: tackling low-density lipoprotein driven cardiovascular risk
30 August 2026
Cardiometabolic pharmacotherapy in complex settings
Congress Session
Cardiometabolic pharmacotherapy in complex settings
30 August 2026
Protection and safety in cardio‑oncology
Congress Session
Protection and safety in cardio‑oncology
30 August 2026
Optimising pharmacotherapy in heart failure
Congress Session
Optimising pharmacotherapy in heart failure
30 August 2026
Clinical Case Management: cardiovascular pharmacotherapeutic considerations in cardiovascular-kidney-metabolic
Congress Session
Clinical Case Management: cardiovascular pharmacotherapeutic considerations in cardiovascular-kidney-metabolic
30 August 2026
New advancements in targeting atherogenic lipoproteins
Congress Session
New advancements in targeting atherogenic lipoproteins
30 August 2026
Lipid lowering and cardiovascular outcomes
Congress Session
Lipid lowering and cardiovascular outcomes
30 August 2026
From guidelines to real-world practice: advancing low-density lipoprotein cholesterol control
Congress Session
From guidelines to real-world practice: advancing low-density lipoprotein cholesterol control
30 August 2026
Targeting platelets post-percutaneous coronary intervention
Congress Session
Targeting platelets post-percutaneous coronary intervention
30 August 2026
Frontiers in anti-inflammatory therapies
Congress Session
Frontiers in anti-inflammatory therapies
29 August 2026
Emerging lipid-lowering therapeutic modalities
Congress Session
Emerging lipid-lowering therapeutic modalities
29 August 2026